肖书娜,高文洁,尚小珂,张长东,钟禹成,智莹,邱林立,董燕斐,何艳,田卫,唐雯雯

• 1:华中科技大学同济医学院附属梨园医院心血管临床医学中心
• 2:华中科技大学同济医院附属协和医院心脏大血管心外科
• 3:武汉市第九医院

摘要(Abstract)：

结合病例评价经皮D-shant心房分流器植入在重度肺动脉高压（PAH）右心衰竭患者的安全性及有效性。1例53岁女性患者，诊断重度特发性PAH合并右心衰竭，世界卫生组织心功能分级Ⅳ级，于2021年11月30日在局部麻醉下行右心导管+D-shant心房分流器植入术。术中选择6 mm×4 cm外周动脉球囊扩张房间隔，植入开口直径4 mm D-shant心房分流器，术后患者症状好转，血流动力学改善。姑息性经皮心房分流器植入以建立右向左分流是治疗晚期PAH患者的另一种方法，具有良好的安全性和有效性。或许是目前耐药重度PAH患者改善症状和延长生存期的另一种替代治疗。

关键词(KeyWords)： 肺动脉高压;心房分流器;球囊房间隔造口术

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 肖书娜,高文洁,尚小珂,张长东,钟禹成,智莹,邱林立,董燕斐,何艳,田卫,唐雯雯

参考文献(References)：

• [1] Zhang R,Dai Lz,Xie WP,et al. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era[J].Chest,2011,140(2):301-309. DOI:10.1378/chest.10-2327.
• [2] Hopkins WE, Ochoa LL, Richardson GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome[J]. J Heart Lung Transplant, 1996,15(1 pt 1):100-105.
• [3] GalièN, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension:the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology(ESC)and the European Respiratory Society(ERS):endorsed by:Association for European Pediatric and Congenital Cardiology(AEPC), International Society for Heart and Lung Transplantation(ISHLT)[J]. Eur Heart J, 2016, 37(1):67-119.DOI:10.1093/eurheartj/ehv317.
• [4] Khan MS, Memon MM, Amin E, et al. Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension:a systematic review and metaanalysis[J].Chest, 2019, 156(1):53-63. DOI:10.1016/j. chest. 2019.03.003.
• [5] D’Armini AM, Callegari G, Vitulo P, et al. Risk factors for early death in patients awaiting heart-lung or lung transplantation:experience at a single European center[J]. Transplantation,1998,66(1):123-127. DOI:10.1097/00007890-199807150-00021.
• [6] Sandoval J. Interventional therapies in pulmonary hypertension[J]. Rev Esp Cardiol(Engl Ed), 2018, 71(7):565-574. DOI:10.1016/j.rec.2018.02.002.
• [7] Rich S,Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension[J]. Am J Cardiol,1983, 51(9):1560-1561. DOI:10.1016/0002-9149(83)90678-1.
• [8] Corris PA. Alternatives to lung transplantation:treatment of pulmonary arterial hypertension[J]. Clin Chest Med, 2011,32(2):399-410.DOI:10.1016/j.ccm.2011.02.015.
• [9] Benza RL, Miller DP, Gomberg-Maitland M, et al.Predicting survival in pulmonary arterial hypertension. Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management(REVEAL)[J].Circulation, 2010, 122(2):164-172. DOI:10.1161/CIRCULATIONAHA.109.898122.
• [10] Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era[J]. Circulation, 2010, 122(2):156-163. DOI:10.1161/CIRCULATIONAHA.109.911818.
• [11] Humbert M, Sitbon O, Ya?ci A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension[J]. Eur Respir J, 2010, 36(3):549-555.DOI:10.1183/09031936.00057010.
• [12] Lehner A, Schulze-Neick I, Fisher M, et al. The creation of an interatrial righttoleft shunt in patients with severe, irreversible pulmonary hypertension:rationale, devices, outcomes[J].Curr Cardiol Rep, 2019, 21(5):31.DOI:10.1007/s11886-019-1118-8.
• [13] Rajeshkumar R, Pavithran S, Sivakumar K, et al. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension[J].Catheter Cardiovasc Interv, 2017, 90(7):1145-1153.DOI:10.1002/ccd.27233.
• [14]中国医师协会心血管内科医师分会结构性心脏病专业委员会，中国医师协会心血管内科医师分会心力衰竭专业委员会，中国医师协会心血管外科医师分会结构性心脏病专业委员会，等.房间隔分流器治疗射血分数保留心力衰竭：中国专家认识和建议[J].中国介入心脏病学杂志，2020, 28(12):656-661. DOI:10.3969/j.issn.1004-8812.2020.12.001.
• [15] Lammers AE, Haworth SG,Diller GP. Atrial septostomy in patients with pulmonary hypertension:should it be recommended[J].Expert Rev Respir Med, 2011, 5(3):363-376.DOI:10.1586/ers.11.25.
• [16]尚小珂，张长东，陈澍，等.首例心房分流器置入术治疗射血分数保留的心衰[J].中华胸心血管外科杂志，2021, 37(5):309-311. DOI:10.3760/cma.j.cn112434-20200603-00278.
• [17]尚小珂，陈澍，董念国，等.治疗心力衰竭的新型器械——心房分流器的研究进展[J].中国介入心脏病学杂志. 2020,28(5):274-276. DOI:10.3969/j.issn.1004-8812.2020.05.007.
• [18]尚小珂，柳梅，张长东，等.中国首例难治性心力衰竭ECMO辅助患者经皮超声引导心房分流器植入[J].中国胸心血管外科临床杂志，2020, 27(12):1503-1504. DOI:10.7507/1007-4848.202010082.
• [19] Patel MB, Samuel BP, Girgis RE, et al. Implantable atrial flow regulator for severe irreversible pulmonary arterial hypertension[J]. EuroIntervention, 2015, 11(6):706-709.DOI:10.4244/EIJY15M07-08.
• [20] Sivakumar K, Rohitraj GR, Rajendran M,et al.Study of the effect of Occlutech Atrial Flow Regulator on symptoms,hemodynamics, and echocardiographic parameters in advanced pulmonary arterialhypertension[J]. Pulm Circ, 2021, 11(1):2045894021989966. DOI:10.1177/2045894021989966.
• [21] D?browska-Kugacka A,Cie?wierz D，?uk G, et al.Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction[J]. Cardiol J,2019,26(1):102-104. DOI:10.5603/CJ.2019.0016.
• [22] Janus M,S?awekSzmyt S,Araszkiewicz A, et al. Atrial flow regulator as a bridge to lung transplant in a young patient with drugresistant idiopathic pulmonary arterial hypertension[J].Kardiol Pol, 2020, 78(5):461-462. DOI:10.33963/KP.15178.
• [23] Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension:state of the art and research perspectives[J]. Eur Respir J, 2019, 53(1)DOI:10.1183/13993003. 01887-2018.
• [24] Manuri L, Calaciura RE, De Zorzi A, et al. Atrial flow regulator for failing Fontan circulation:an initial European experience[J].Interact Cardiovasc Thorac Sur, 2018, 27(5):761-764. DOI:10.1093/icvts/ivy165.
• [25] Micheletti A, Hislop AA, Lammers A, et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension[J]. Heart, 2006, 92(7):969-972.DOI:10.1136/hrt.2005.077669.
• [26] Huertas A, Guignabert C, BarberàJA, et al. Pulmonary vascular endothelium:the orchestra conductor in respiratory diseases:highlights from basic research to therapy[J]. Eur Respir J,2018, 51(4):1700745. DOI:10.1183/13993003.00745-2017.
• [27]中华医学会呼吸病学分会肺栓塞与肺血管病学组，中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会，全国肺栓塞与肺血管病防治协作组，等.中国肺动脉高压诊断与治疗指南（2021版）[J].中华医学杂志，2021, 101(1):11-51.DOI:10.3760/cma.j.cn 112137-20201008-02778.
• [28] McLennan D, Ivy D, Morgan GJ. Transvenous implantation of the Occlutech atrial flow regulator:preliminary results from swine models[J]. Congenit Heart Dis, 2019, 14(5):819-831.DOI:10.1111/chd.12816.